BIOMAT Database Logo BIOMAT Database Logo

[Insulin receptors in syndromes involving acanthosis nigricans and severe insulin resistance]. 1982

M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000052 Acanthosis Nigricans A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder. Acanthosis Nigrican,Nigrican, Acanthosis,Nigricans, Acanthosis
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D048909 Diabetes Complications Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. Complications of Diabetes Mellitus,Diabetes-Related Complications,Diabetic Complications,Diabetes Complication,Diabetes Mellitus Complication,Diabetes Mellitus Complications,Diabetes Related Complications,Diabetes-Related Complication,Diabetic Complication

Related Publications

M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
Insulin receptors, acanthosis nigricans, and insulin resistance.
March 1986, Lancet (London, England),
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
Syndromes associated with insulin resistance and acanthosis nigricans.
January 1998, Journal of basic and clinical physiology and pharmacology,
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
Characterization of insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans.
March 1980, Diabetologia,
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
INSULIN RESISTANCE AND ACANTHOSIS NIGRICANS.
January 1964, Diabetes,
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
Acanthosis nigricans and insulin resistance.
May 1984, Journal of the American Academy of Dermatology,
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
[Insulin resistance and acanthosis nigricans].
January 1985, Acta clinica Belgica,
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.
April 1976, The New England journal of medicine,
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
[Acantosis nigricans in severe insulin resistance syndromes].
March 2017, Anales de pediatria (Barcelona, Spain : 2003),
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
Autophosphorylation of cultured skin fibroblast insulin receptors from patients with severe insulin resistance and acanthosis nigricans.
March 1989, Diabetes,
M Muggeo, and V Businaro, and P P Faronato, and P Moghetti, and A Valerio, and E Cardin-de' Stefani, and G C Chieregato
Acanthosis nigricans, hypothyroidism, and insulin resistance.
July 1986, The American journal of medicine,
Copied contents to your clipboard!